INTRODUCTION
Sellar masses occur in 0.1% of the population and represent 14-18% of intracranial tumors. Hemorrhage is an uncommon finding, only occurring in 1.6-2.8% of pituitary adenomas which account for 85% of sellar tumors. [1, 5] Sellar masses with suprasellar extension presenting with intraventricular hemorrhage (IVH) are rare; even more uncommon are atypical teratoid/ rhabdoid malignant sellar tumors atypical teratoid/rhabdoid tumor (ATRT) in adults. In fact, there were only 21 cases of adult sellar ATRT tumors in the literature before this case [ Table 1 ]. e diagnosis of a sellar ATRT is a pathological diagnosis (e.g., characteristic loss of integrase interactor 1 (INI1) expression on immunohistochemistry and elevated Ki67 proliferation index). [3] Here, we present an adult whose hemorrhagic sellar mass resulted in an extensive IVH and subarachnoid hemorrhage (SAH) that was eventually diagnosed to be an ATRT.
CASE REPORT
A 55-year-old female presented with 1 week of headache, blurred vision, and the acute onset of altered mental status. On examination, she opened her eyes to voice, followed commands in all four extremities, and had a slight right hemiparesis. She also exhibited panhypopituitarism and hypernatremia secondary to diabetes insipidus.
Computer tomography and magnetic resonance findings e brain computer tomography (CT) revealed a suprasellar cistern and anterior interhemispheric SAH with IVH; this required placement of a right ventricular drain [ Figure 1 ]. e brain magnetic resonance imaging (MRI) with and without contrast also demonstrated a moderately enhancing, expansive sellar mass with internal hemorrhage, extending into the suprasellar space. ere was uniform enhancement throughout most of the mass, except for its most dorsal aspects which heterogeneously enhanced. ere was also an invasion of the right cavernous sinus, protrusion into the sphenoid sinus, and mass effect on the optic chiasm [ Figure 2 ].
Computer tomography and cerebral angiography
e CT angiogram suggested a 3 mm right supraclinoid internal carotid artery aneurysm. Two cerebral angiograms performed 3 days later showed incidental pathology (e.g., 2 mm left middle cerebral artery bifurcation aneurysm; left anterior choroidal artery aneurysm; and a 2 mm right paraophthalmic aneurysm), which was not considered to be contributing to her symptomatology.
Surgery
Transsphenoidal resection of the pituitary mass and evacuation of the sellar hematoma were undertaken. e frozen and permanent pathology was negative for hormonal stains. She was, therefore, originally diagnosed as having a pituitary adenoma with apoplexy and recovered within weeks without a persistent neurological deficit.
Six-week postoperative readmission
Six weeks later, however, she developed worsening of the headaches accompanied by visual loss. e MRI now showed a significant interval increase in the size of the sellar/suprasellar enhancing mass with the invasion of the cavernous sinus and encasement of the internal carotid arteries bilaterally [ Figures 3 and 4 ]. She underwent a right frontal craniotomy for tumor debulking. e mass was highly vascular, and only partial debulking was achievable. Additional stains showed INI1 loss in neoplastic cells, and an elevated Ki67 proliferation index; both were characteristic for an ATRT (i.e., the World Health Organization Grade IV). Postoperatively, the patient remained intubated and followed commands intermittently for several days. She then, however, suddenly developed a dilated and fixed right pupil along with extensor posturing. When the repeated brain CT showed the tumor had re-bled, the family chose only palliative measures; the patient subsequently expired.
DISCUSSION
ATRT typically is a central nervous system tumor, most commonly found in the posterior fossa. [3] It is typically diagnosed in infants <2 years of age and is associated with poor clinical outcomes. In adults, only about 50 cases of ATRT have been reported; 21 involved the sella and/ or suprasellar cistern. [9, 20] Notably, ATRT in adults has a more favorable clinical course than in children and carries a mean survival time of 23 months. [4] Common clinical presenting features of sellar ATRTs include strictly females, onset from ages 20 to 69, presentation with persistent blurry vision, headache, ophthalmoplegia, and features of hypopituitarism. [4, 8] Behavior of sellar atypical teratoid/rhabdoid tumor Sellar ATRT rapidly recurs after transsphenoidal resection; this also occurred in our patient. Of the previously reported adult sellar/suprasellar ATRT cases, only one presented with SAH and IVH [4, 19] [ Table 1 ].
Figure 4:
Magnetic resonance imaging sella, coronal T1-WI with contrast shows the mass now extending into the bilateral cavernous sinuses, right greater than left, and encasing the internal carotid arteries. Table 1 : Summary of adult-onset sellar/suprasellar ATRT data in past publications.
Authors (year) Age (years) Gender Symptoms Initial resection IVH/SAH Survival time
Kuge et al. [11] 32 Female Visual disturbance, headache Subtotal No 28 months
Raisanen et al. [21] 20 Female Visual disturbance Total, with recurrence No Alive at 28 months Raisanen et al. [21] 31
Female Not stated Total No 9 months Arita et al. [3] 56
Female diplopia, headache Subtotal No 23 months Las Heras and Pritzker [13] 46
Female headache Not stated Not stated Not stated Schneiderhan et al. [22] 57 Female Diplopia, headache Total, with recurrence No Alive at 6 months Schneiderhan et al. [22] 61 Female Diplopia Subtotal No 3 months Moretti et al. [15] 60 Female Headache, diplopia Total, with recurrence No 30 months Chou et al. [10] 43 Female Headache, diplopia Subtotal No Alive at 2 weeks Park et al. [20] 42
Female Visual disturbance Subtotal No Alive at 27 months Shitara and Akiyama [23] 44
Female Visual disturbance Subtotal, with recurrence
No 17 months
Biswas et al. [7] 48 Female Visual disturbance Total, with recurrence No 2 months Lev et al. [14] 36 Female Headache, diplopia Total, with recurrence No 29 months Nobusawa et al. [18] 69 Female Diplopia Subtotal No Alive at 24 months Larrán-Escandón et al. [12] 43 Female Headaches, diplopia Subtotal No 35 days Barresi et al. [5] 59
Female Headache, diplopia Subtotal No 2 months Almalki et al. [2] 36 Female Headache, diplopia, nausea, vomiting Subtotal No Alive at 37 months Nakata et al. [16] 21 Female Not stated Total Not stated 17 months Nakata et al. [16] 26
Female Not stated Total Not stated 33 months Nishikawa et al. [17] 
Radiographic presentation of sellar atypical teratoid/ rhabdoid tumor on computer tomography
On CT, Biswas et al. described ATRT as hyperdense lesions with heterogeneous enhancement, and calcifications (40%). [7] Alternatively, pituitary adenomas are typically isodense on CT with rare calcifications. [6] Pathology of atypical teratoid/rhabdoid tumor Key distinguishing features of ATRT are an elevated Ki67 proliferation index, and the loss of INI1 protein expression due to partial deletion of chromosome 22 (e.g., which contains the SMARCB1 gene). e latter two findings were noted in our patient's pathology report. [7, 18, 21] 
Treatment of atypical teratoid/rhabdoid tumor
At present, there is no standard treatment for sellar ATRT. Although various therapies have been attempted including resection, radiation, and chemotherapy, they have been met with varying success and are largely based on pediatric protocols. [6, 9, 20] 
CONCLUSION
A 55-year-old female acutely presented with a sellar ATRT characterized by both a subarachnoid and IVH. Although the initial diagnosis was pituitary apoplexy attributed to an adenoma, the secondary bleed led to further histopathological confirmation of an ATRT (e.g., INI1 expression and elevated Ki67 proliferation index).
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